Background: Alteration in the concentration of inflammatory cytokines may contribute to pathogenesis in sickle cell anaemia (SCA). Vitamin D may suppress pro-inflammatory cytokines and enhance anti-inflammatory cytokines. Objective: To compare steady state levels of pro-and anti-inflammatory cytokines of Nigerian SCA children with age-and sex-matched healthy controls, and determine the relationship with 25-hydroxyvitamin-D (25-OHD). Effects of three months of vitamin D supplementation on cytokines of SCA children with suboptimal 25-OHD were also evaluated. Methods: Serum 25-OHD, 2, 6, 8, 11, 12, 13, 17, 18 of 95 SCA children and 75 matched controls were determined using HPLC. The 12 SCA children with suboptimal 25-OHD received 2000 IU of vitamin D daily for 3 months, and their post supplementation cytokines and 25-OHD levels were compared with the baseline values. Results: IL-2, 6, 8, 12, 17 and 18 were higher in SCA children than the controls (p ≤ 0.001), but no significant variation in IL-11 and 13 (p = 0.131 and 0.057 respectively). Patients with suboptimal serum 25-OHD had higher IL-6, 8 and 18 (p = 0.003, 0.010 and 0.002 respectively) and lower levels of IL-11 (p = 0.005). Significant positive treatment effects were observed: post-supplementation, serum 25-OHD increased by 23.3 ng/mL, p < 0.001; proinflammatory cytokines IL-2, 6, 8, 17 and 18 (p < 0.001) were reduced and anti-inflammatory cytokine IL-11 was increased, p < 0.001. Conclusions: Suboptimal 25OHD is associated with enhanced levels of pro-inflammatory markers in children with SCA. Three months of daily vitamin D supplementation reversed the trend. Hence; Vitamin D supplementation may reduce the inflammatory milieu and serve as an anti-inflammatory agent in the management of SCA.
Introduction
Haemolysis and microvascular occlusion are the two main pathophysiological processes involved in the clinical phenotypes of sickle cell disease (SCD) [1] [2] [3] . Recurrent vascular occlusion causes painful crises and may ultimately lead to the development of end-organ dysfunction, the most common cause of mortality in adults with SCD [3] . Haemolysis leads to increase in free plasma haemoglobin, and eventual depletion of haemoglobin scavengers such as haptoglobin, hemopexin, soluble CD163 and nitric oxide (NO) [2, 4] . Low plasma level of NO causes vasoconstriction, activation of cell adhesion molecules and enhanced platelet aggregation to the vascular endothelium. These events cause endothelial damage and a cascade of inflammatory processes involving mediators such as cytokines and chemokines and eventual endothelial hyperplasia and vascular occlusion [5] .
Several studies have linked chronic inflammation with the pathogenesis of vasoocclusive pain crises (VOC) in SCD [4] [5] [6] , with chronic inflammation resulting from imbalance in the production and activity of pro-and anti-inflammatory molecules [7] . Even in steady state, there is evidence of on-going increased expression of cytokines, endothelial activation and dysfunction [7] .
In a vicious cycle, the released cytokines enhance activation of the vascular endothelium, erythrocytes, leucocytes and platelets and the adhesion of these blood elements to the vascular wall; events that http://dx.doi.org/10.1016/j.cyto.2017.03.010 Received 13 November 2016; Received in revised form 12 January 2017; Accepted 31 March 2017 culminate in VOC [5, 8] . In SCD, levels of pro-inflammatory cytokines are elevated while anti-inflammatory cytokine levels are decreased during VOC and in steady state when compared with healthy non-SCD subjects [9] [10] [11] . The levels also differ in SCD patients with VOC and those in steady state [11] .
Cytokines are soluble factors that are released by immune cells, and in turn, are involved in differentiation, maturation and activation of immune cells. Pro-inflammatory cytokines such as interleukins (IL)-1β, 2, 6, 8, 12, 17 and 18 upregulate a number of chemokines leading to recruitment of neutrophils into the sites of inflammation [5] . Antiinflammatory cytokines such as IL-10, 11 and 13 are series of immunoregulatory molecules that control the pro-inflammatory cytokine response, with the aim of regulating human immune response [12] . Helper T (CD4 + ) cells and cytotoxic/suppressor T (CD8 + ) cells are reportedly normal in children with SCD. While the latter produces IL-4, 5, 6, 9, 10, 13 and are involved in humoral immunity, the former produces IL-1, 2 and 12 and are associated with innate immunity [13] . However, imbalance in these cytokines is implicated in SCD pathogenesis. Excessive expression and activity of Th1 cytokines such as IL-2, Tumor Necrotic Factor (TNF)-β and Interferon (IFN)-γ induces exaggerated cell-mediated immunity, while predominance of Th2 cytokines (IL-4, 5, 6, 9 and 10) leads to excessive humoral immunity [13] . Vitamin D supplementation has been found to suppress proinflammatory cytokines such as interleukin-6 and 8 in patients with acute congestive cardiac failure [14] . Previous in vitro studies also showed that calcitriol, vitamin D3, can suppress the release of TNF-α [15] and up-regulates the synthesis of the anti-inflammatory cytokine interleukin 10 (IL-10) by inducing IL-10 receptor expression [16] . Vitamin D is also said to regulate the adaptive immune responses in many inflammatory and autoimmune disorders [17, 18] . The biological basis for this role has been linked to the expression of vitamin D receptor (a ligand activated transcription factor) and CYP27B1 (a vitamin D activating enzyme, α-hydroxylase) in cells that are involved in immune/inflammatory systems such as macrophages, monocytes, dendritic cells and Tlymphocytes. Vitamin D supplementation may therefore alleviate the inflammatory milieu and serve as a new anti-inflammatory intervention in the management of diseases characterised by acute and or chronic inflammation such as SCD.
Studies on the relationship between vitamin D and cytokines are scanty, and none has been conducted among SCD patients. Since SCD has been described as a chronic inflammatory condition, this study aims to determine the serum levels of pro-and anti-inflammatory cytokines in children with SCA and compare with haemoglobin AA matched controls. In addition, because of the postulated anti-inflammatory property of vitamin D, we examined the relationship that exists between serum cytokine levels and 25-hydroxyvitamin D (25-OHD) in the patients and the effects of daily vitamin D supplementation on these cytokines.
Subjects and methods

Study location and subjects recruitment
This cross-sectional comparative study consisted of 95 children with SCA in steady state and 75 age-and sex-matched apparently-healthy children with haemoglobin AA from the same locality. The subjects with SCA were drawn from patients attending the Paediatric Haematology Clinic of Obafemi Awolowo University Teaching Hospital, Ile-Ife, Nigeria (Wesley Guild Hospital Ilesa Unit) and the controls were the accompanying non-SCD siblings of the patients and those attending Children Welfare Clinic of the hospital for routine preschool medical tests. Steady state was defined as a period during which a child with SCA is free of crisis (pain or haemolytic), infection and any other acute illness for at least four weeks after the last episode of crisis and at least three months after the last blood transfusion [19] . Those on chronic blood transfusion program, those using vitamin D for any reason and those whose parent or guardian refused consent were excluded. The Ethical Research and Review Committee of the Hospital approved the study protocol. Written informed consent was obtained from the parents/caregivers, and assent was also obtained from children ≥7 years after the purpose of the study was explained to them.
Data collection
Data on the socio-demographics (age, sex and socioeconomic status) were obtained from each patient through a pretested questionnaire. Socioeconomic status was determined using the occupation of the father and the highest academic qualification of the mother according to Olusanya et al. [20] . The father's occupation has scores ranging from 1 to 3, while the mother's educational qualification has scores from 0 to 2. The total score was then calculated for each patient. The minimum and maximum possible scores are 1 and 5 respectively. Those with a total score of 1 or 2 are in the upper social class (i.e. social class 1); total score of 3 for middle social class (social class 2) and score of 4 or 5 for lower social class (social class 3).
Clinical history and physical findings were also obtained through a pretested questionnaire and/or by review of relevant medical charts. The number of SCD-related blood transfusions, hospitalization, and significant pain episodes requiring analgesia and hospital visit in the previous 12 months were documented.
Laboratory estimation of cytokines, serum 25-OHD and complete blood count
For each patient, 5-mL of venous blood samples was taken at the time of recruitment. Complete blood count (CBC) was done with autohemoanalyser Pentra 60, Horiba® immediately after blood collection at the Haematology laboratory of the hospital. Serum samples were obtained following centrifugation at 3000 rpm for 10 min and immediately transferred to the Chemical Pathology Laboratory of the hospital for storage at −20°C until analysed within 3 months of collection. At the time of analysis, the serum samples were transported on dry ice to the Central Laboratory of the International Institute of Tropical Agriculture (IITA), Nigeria, about 100 km away from the hospital for cytokine and 25-OHD quantification.
Cytokines (interleukin-1β, 2, 6, 8, 11, 12, 13, 17, 18 ) and 25-OHD were quantified using an automated Waters 616/626S Transducer Pump high performance liquid chromatography (HPLC) machine at a wavelength of 198 nm. Quantification of individual cytokine and 25-OHD levels was obtained using the linear regression equation previously generated from the calibration curve. Serum levels of 25-OHD less than 20 ng/ml were considered deficient, values ≥20 ng/ml but < 30 ng/ml as insufficient, values ≥30 ng/ml as sufficient [21] . Hence, value < 30 ng/mL was described as suboptimal serum vitamin D. Highly sensitive (Hs)-CRP ELISA kit, manufactured by Monobind Inc, 100 North Point drive, Lake Forest (Product code-3125-300) was used for CRP quantification, and results reported in µg/ml.
Vitamin D supplementation
SCA children with suboptimal vitamin D levels (< 30 ng/mL) were studied further. They were given 2000 IU/day of vitamin D3 supplement (cholecalciferol -Kirkland Signature Extra Strength Vitamin D3; Costco Wholesale Corporation, USA) for a period of three months, the minimum time that is usually taken for vitamin D supplementation to reach a plateau of circulating 25-OHD concentrations [22] . However, each child was seen and their supplements refilled monthly. The compliance was documented by controlling the study medication at each visit (bottle counts). The primary study endpoints were haematocrits, serum 25-OHD, pro-inflammatory cytokines interleukins-1β, 2, 6, 8, 12, 17, 18 and anti-inflammatory cytokines IL-11 and 13. Blood specimens were collected from the antecubital vein of the study participants at baseline (before supplementation) and after 3 months of supplementation.
Statistical analysis
The data were analysed using the Statistical Package for the Social Sciences software (version 20.0; SPSS Inc., Chicago package). Independent sample t test, Mann-Whitney test, analysis of variance (ANOVA), Kruskal Wallis tests and Spearman correlation analysis were used for comparisons of the continuous data among different groups such as the differences in serum cytokines between the subjects and the controls, as well as the relationships between 25-hydroxyvitamin D level and serum cytokine levels. Possible associations between categorical variables were tested by chi square test or Fisher's exact test. Paired t test was used to compare the cytokine values of the SCA group with suboptimal serum 25-OHD at baseline with values at the end of the third month. Results after 3 months were presented as the change from baseline. P values ≤ 0.05 in a two-tailed test were considered statistically significant.
Results
Sociodemographic and haematologic characteristics of the study population
The study population included 95 children with homozygous SS and 75 age-and sex-matched children with HbAA. The mean ages of the two groups were statistically similar (7.35 ± 2.47 years and 6.80 ± 2.57 years respectively, p = 0.160). The demographic characteristics, as well as their haematological parameters, are presented in Table 1 . Fifty-two (54.7%) of the SCA subjects and 45 (60.0%) of the controls were male. While the total leucocyte counts, MCV and platelet counts were significantly higher in children with SCA (p < 0.001, 0.043 and < 0.001 respectively), haematocrit was significantly lower, 23.47 ± 3.62% versus 35.90 ± 2.96%, p < 0.001.
Serum 25-OHD status of the patients and the controls
The mean serum 25-OHD of the 95 children (41.89 ± 9.81 ng/ml) with SCA was significantly lower than the 45.22 ± 8.19 ng/ml of the 75 with haemoglobin AA genotype, p = 0.017, 95% CI = 1.6-6.1 (Table 2) . Similarly, more children, 12 (12.6%) of those with SCA as against two (2.7%) of the controls had suboptimal serum 25-OHD, p = 0.013, 95% CI = 1.1-24.4. The 12 SCA children with suboptimal serum 25-OHD comprised two (2.1%) with vitamin D deficiency (< 20 ng/mL) and 10 (10.5%) with vitamin D insufficiency (20-29.9 ng/mL).
Serum levels of inflammatory cytokines in patients and controls
The mean serum levels of pro-inflammatory cytokines IL-2, 6, 8, 12, 17 and 18 were significantly higher among children with SCA than the controls, p ≤ 0.001. There was however no significant variation in the mean serum levels of the anti-inflammatory cytokines IL-11 and 13 between the two groups, p = 0.131 and 0.057 respectively ( Table 3) .
The mean C-reactive protein (CRP) of the SCA children was 9.2 ± 10.2 µg/mL, while that of the healthy controls was 1.8 ± 3.1 µg/mL. The median serum CRP concentrations were significantly higher in children with SCA than the healthy controls, 5.7 µg/ mL vs. 0.9 µg/mL, Z = −8.650, p < 0.001.
Relationship between serum 25-OHD and inflammatory cytokines
Among the 95 children with SCA, 12 (12.6%) had suboptimal 25-OHD level (< 30 ng/mL), comprising of two (2.1%) with vitamin D deficiency (< 20 ng/mL) and 10 (10.5%) with vitamin D insufficiency (20-29.9 ng/mL). As shown in Table 4 , the mean serum pro-inflammatory cytokines (IL-6, 8 and 18) of those with suboptimal vitamin D were significantly higher than those with normal serum vitamin D, p = 0.003, 0.010 and 0.002 respectively. For circulating IL-1β, the mean value was however lower among those with suboptimal serum vitamin D than those with normal 25-OHD, p = 0.001. There was no significant difference in the mean serum pro-inflammatory IL-2, 12 and 17 levels between the two groups, p = 0.458, 0.147 and 0.628 respectively. Serum anti-inflammatory cytokine IL-11 was higher among SCA patients with normal serum vitamin D than those with suboptimal 25-OHD, p = 0.005. IL-13 was similar between the groups, p = 0.080.
Although all pro-inflammatory interleukins (except IL-1β) had inverse correlation with serum vitamin D using Spearman correlation analysis, the association was significant only with IL-8, r = −0.24, p = 0.020 (Fig. 1 ). IL-1β had a significant positive correlation with the vitamin, r = 0.34, p = 0.001 (Fig. 2) . There was however no correlation between serum 25-OHD and any of the anti-inflammatory cytokines. 
Effects of vitamin D supplementation on cytokine profiles of the 12 SCA children with suboptimal levels of serum 25-OHD
At the end of the third month, all the 12 patients had improvement in the level of 25-OHD, though one patient still had value < 30 ng/ml. Compared with the baseline, significant positive treatment effect was observed (serum 25-OHD increased by 23.3 ng/mL, 95% CI = 19.7-26.9, p < 0.001). Also, as shown in Table 5 , pro-inflammatory cytokines IL-2, 6, 8, 17 and 18 were significantly reduced while anti-inflammatory cytokine, IL-11 was significantly higher after 3 months of vitamin D3 supplementation, p < 0.05 in each case.
Discussion
Expression of cytokines with attendant inflammation, cell adhesion to vascular endothelium and consequent endothelial injury, contribute to vaso-occlusion in SCD [6, 11] . Although several efforts have been made to link alterations in the levels of inflammatory cytokines to vasoocclusive crisis pathophysiology, conclusions are still largely inconsistent [6, 8, 23, 24] . In this study, the serum level of pro-inflammatory cytokines 2, 6, 8, 12, 17, 18 were significantly higher among children with SCA than age-matched healthy controls. This is consistent with many reports that documented increased expression of pro-inflammatory cytokines in SCD, not only during VOC, but even in steady state [24] [25] [26] . During steady state period, subclinical microvascular occlusions also occur because of persistent local tissue ischaemia, as well as ongoing haemolysis. These events (i.e. local tissue ischaemia and ongoing haemolysis) result in chronic endothelial activation/ dysfunction and chronic inflammation characterised by the production of proinflammatory cytokines. However, the degree of endothelial activation and expression of these cytokines are not usually high enough to cause painful episodes [24] .
Interestingly, in this study the level of pro-inflammatory cytokine 
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IL-1β was higher among healthy controls than SCA patients. Taylor et al. in their study on the in vivo production of type 1 cytokine in healthy SCD patients, reported no significant, detectable levels of IL-1β in the serum of SCD patients and controls [27] . Keikhaei et al. also reported that healthy controls had marginal increase in serum IL-1β among controls than SCD in steady state [10] . Qari et al. in 2012 observed higher levels of IL-1β in SCA in steady state compared to those with painful crisis [28] . Hence, although IL-1β is classified as proinflammatory cytokines, its level may be comparable to, or even higher in healthy individuals than SCD patients. The exact mechanism to explain this inconsistent finding in the levels of IL-1β in SCD patients is unknown, nevertheless, its levels have been found to be a good predictor of stroke outcome in children with SCD [29] . High levels of IL-1β had been associated with protection against stroke development in children with abnormal transcranial Doppler findings [29] . Consistent with previous studies, increased levels of IL-6 were observed in our patients (SCA in steady state) than the controls. Hibbert et al. [30] in establishing a baseline pattern of circulating pro-inflammatory cytokines in homozygous SS children in Atlanta, Georgia, found that IL-6 was significantly higher among the SCA group than the controls. Pathare et al. [3] also documented similar findings about IL-6 in SCD patients. In addition, they observed that there was a significant increase in IL-6 levels in those with VOC when compared with those in steady state. Veiga et al. [31] reported elevated production of IL-6 in Brazilian SCA patients with periodontal inflammation than matched controls, though the difference did not reach statistical significance. These findings support the roles of cytokines in inflammation through promotion of cellular differentiation, maturation, proliferation and survival [31] . However, in a study among SCA children with a history of chronic transfusion therapy at Children's Hospital and Research Center, Oakland, IL-6 levels were surprisingly found to be significantly higher during steady state than during painful crisis [32] . The conflicting reports on the levels of IL-6, especially between VOC and steady state, justify the need for further studies on the role of this interleukin in SCA.
Similarly, IL-8 levels were significantly higher among SCA patients than controls in this study. Keikhaei et al. reported similar findings and suggested that IL-8 could be a useful marker of inflammation in SCD patients, not only during painful episodes, but also during steady state [10] .
IL-12, 17 and 18 were also observed to be significantly higher among our patients than their haemoglobin AA counterparts. Although these cytokines have defined roles in immune mediation, there are only few reports in the literature on their roles in SCD pathogenesis, which are also unclear [3] . In non-SCD population, IL-12 regulates innate and adaptive immunity and induces production of other cytokines such as interferon-γ (IFN-γ). IL-17 is important in allergic responses and production of other inflammatory cytokines and chemokines. In SCD, there have been conflicting reports about the levels of these cytokines. Among SCA patients with leg ulcers, Silva et al. [5] , for the first time [87] [88] [89] [90] [91] [92] [93] showed that high levels of IL-17 were associated with absence of acute chest syndrome (ACS) and high levels of lactate dehydrogenase enzyme, and concluded that IL-17 may exert a preventive role in ACS and serve as a marker of haemolysis in this group of patients. In the present study, IL-11 and 13 were the only anti-inflammatory cytokines that were examined. Surprisingly, their levels were comparable in both SCA and control groups. One would have expected a lower level among SCA patients. Reports about these cytokines are scanty. However, understanding their roles in the pathology of SCD may help in developing new and effective treatment strategies for this disease.
We observed from the present study that SCA children with suboptimal serum 25-OHD had significantly higher levels of proinflammatory cytokines (IL-6, 8 and 18) and lower levels of antiinflammatory cytokines (IL-11) than those with normal levels of serum 25-OHD. In addition, pro-inflammatory cytokine IL-8 had significant inverse correlation with serum 25-OHD levels. These relationships support the anti-inflammatory/immunomodulatory properties of vitamin D. Hence, in addition to its effects on bone health and prevention of respiratory diseases and haemolysis [33] , this study adds to the increasing evidence on the preventive effects of vitamin D on immune dysfunction. Vitamin D regulates the production of inflammatory cytokines and inhibit the proliferation of pro-inflammatory cells; the two main mechanisms involved in the pathogenesis of inflammatory diseases [34] .
Consistent with our results, some epidemiological studies have demonstrated an inverse relationship between circulating levels of 25-OHD and pro-inflammatory markers such as IL-6 and C-reactive protein [33, 35] . Hummel et al. found that pro-inflammatory cytokines IL-6 and tumor necrotic factor (TNF)-α depress vitamin D metabolism and hence its level, by inhibiting the expression of vitamin D activating enzymes CYP27B1. They concluded that presence of pro-inflammatory cytokines IL-6 and TNF-α limit the anti-inflammatory action of vitamin D [33] .
Emerging evidence from clinical studies has shown that suboptimal vitamin D, especially vitamin D deficiency is associated with several inflammatory conditions such as asthma, cardiovascular diseases (coronary artery disease, dyslipidemia, hypertension), type 2 diabetes mellitus, inflammatory bowel disease, chronic kidney disease, prostate and breast problems, multiple sclerosis and non-alcoholic fatty liver disease [34, 36] . However, whether this association is causally related or simply a marker/manifestation of the disease is still uncertain. To understand this, we gave daily vitamin D3 supplementation to all the 12 SCA children with suboptimal vitamin D levels and followed them for three months to determine the effects of supplementation on serum cytokines, the biomarkers of inflammation. We found that all the 12 patients had improvement in the level of 25-OHD, with only one having values less than 30 ng/ml at the end of the third month. The serum 25-OHD increased by 23.3 ng/mL. Also, we showed for the first time that a daily supplement of 2000 IU vitamin D for 3 months is able to increase serum concentrations of the anti-inflammatory cytokine IL-11 and lower pro-inflammatory cytokines IL-2, 6, 8, 17 and 18 in children with SCD.
Clinical data on the effects of vitamin D3 supplementation on cytokine profiles are scanty. Schleithoff et al. [14] in their doubleblind randomized, placebo-controlled trials of vitamin D3 supplementation in patients with congestive heart failure, reported improvement in the levels of anti-inflammatory cytokine IL-10 after 9 months. The pro-inflammatory cytokines TNF-α continued to increase in the patients on placebo but remained constant in vitamin D3 group [14] .
Our study has some limitations. First, adherence to daily medications is challenging for children with SCD and their care providers. Providing monthly vitamin D supplementation during hospital visits to those with deficiency may be a better alternative and might have led to a better outcome. Also, the few number of children with suboptimal levels of vitamin D who eventually had supplementation was a major limitation. Thirdly, only two anti-inflammatory cytokines, namely IL-11 and IL-13 were measured. Measurement of some other anti-inflammatory cytokines such as IL-4 and IL-10 could have strengthened the observed anti-inflammatory property of vitamin D in these children. The study was also not a randomised controlled one.
Conclusions
Our findings, suggest that vitamin D3 may reduce the inflammatory milieu in children with SCD and might serve as a new anti-inflammatory agent for the future treatment of the disease. The few available evidence therefore suggest that regular screening for vitamin D and supplementation may be beneficial in conditions characterised by chronic inflammation and high prevalence of vitamin D deficiency such as SCD.
"What is already known on this topic"
• Vitamin D supplementation has been found to suppress proinflammatory cytokines such as interleukin-6 and 8.
• In SCD, chronic inflammation results from imbalance in the production and activity of pro-and anti-inflammatory molecules, even in steady state.
"What this study adds"
• We showed for the first time that daily supplement of vitamin D increased serum anti-inflammatory cytokine and lower pro-inflammatory cytokines in children with SCD.
• Vitamin D3 might serve as a new anti-inflammatory agent for the future treatment of SCD.
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